Consensus Recommendations for Management and Counseling of Adverse Events Associated With Lorlatinib: A Guide for Healthcare Practitioners
Crossref DOI link: https://doi.org/10.1007/s12325-020-01365-3
Published Online: 2020-05-12
Published Print: 2020-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Reed, Mollie
Rosales, Aimee-Lauren S.
Chioda, Marc D.
Parker, Lindsey
Devgan, Geeta
Kettle, Jacob
Funding for this research was provided by:
Pfizer Inc.
Text and Data Mining valid from 2020-05-12
Version of Record valid from 2020-05-12
Article History
Received: 30 January 2020
First Online: 12 May 2020